Toggle Sidebar
Tracking
The Digest
Dashboard
Changes
Readouts
Trials
Companies
Comparisons
Automation
Nightly sweep
Settings
Tracker
↳
Sign in
Sign in
Explore the registry
Track Mirdametinib's trials
Effect of Hepatic Impairment on the Pharmacokinetics of Mirdametinib
Mirdametinib (MEK Inhibitor)
Ongoing
Recruiting
Phase 1
Open NCT06997276 on ClinicalTrials.gov ↗
Population
Loading…
Intervention
Loading…
Comparator
Loading…
Outcomes
Loading…
Overview
Endpoints
Eligibility
Full record
